Liver cancer, especially hepatocellular carcinoma (HCC), poses a significant health challenge worldwide. Recent strides in cancer research are revolutionizing its diagnosis and treatment. Advances in genomic profiling are uncovering critical molecular mechanisms, paving the way for tailored therapies. Immunotherapy, particularly with immune checkpoint inhibitors, is showing encouraging results by boosting the body's immune response against cancer cells. Additionally, innovative imaging techniques are enhancing the early detection and monitoring of liver tumors. Researchers are also investigating combination therapies that merge traditional methods like surgery and chemotherapy with new treatments to achieve better outcomes. Ongoing research is vital to fully understand liver cancer and develop more effective, targeted therapies.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States